Association study of GABA system genes polymorphisms with amphetamine-induced psychotic disorder in a Han Chinese population.
Methamphetamine psychosis: epidemiology and management.
Glasner-Edwards S, Mooney LJ.
CNS Drugs. 2014 Dec;28(12):1115-26. doi: 10.1007/s40263-014-0209-8.
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Buoli M, Serati M, Cahn W.
Expert Rev Neurother. 2016;16(2):131-44. doi: 10.1586/14737175.2016.1135735. Epub 2016 Jan 14.
Risk of Incident Psychosis and Mania With Prescription Amphetamines.
Moran LV, Skinner JP, Shinn AK, Nielsen K, Rao V, Taylor ST, Cohen TR, Erkol C, Merchant J, Mujica CA, Perlis RH, Ongur D.
Am J Psychiatry. 2024 Oct 1;181(10):901-909. doi: 10.1176/appi.ajp.20230329. Epub 2024 Sep 12.
Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.
Moran LV, Ongur D, Hsu J, Castro VM, Perlis RH, Schneeweiss S.
N Engl J Med. 2019 Mar 21;380(12):1128-1138. doi: 10.1056/NEJMoa1813751.
The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy'), methamphetamine and D-amphetamine.
Steinkellner T, Freissmuth M, Sitte HH, Montgomery T.
Biol Chem. 2011 Jan;392(1-2):103-15. doi: 10.1515/BC.2011.016.
Psychosis with use of amphetamine drugs, methylphenidate and atomoxetine in adolescent and adults.
Hamard J, Rousseau V, Durrieu G, Garcia P, Yrondi A, Sommet A, Revet A, Montastruc F.
BMJ Ment Health. 2024 Apr 12;27(1):e300876. doi: 10.1136/bmjment-2023-300876.
Characteristics of Amphetamine Psychosis with Respect to the Length of Drug Exposure.
Babina A, Sokolova I, Vysotskyi M.
CNS Neurol Disord Drug Targets. 2023;22(4):599-606. doi: 10.2174/1871527321666220726141936.
Psychostimulant use and the brain.
Lappin JM, Sara GE.
Addiction. 2019 Nov;114(11):2065-2077. doi: 10.1111/add.14708. Epub 2019 Jul 19.
Efficacy of probiotic supplements in improving the symptoms of psychosis, anxiety, insomnia, and anorexia due to amphetamine and methamphetamine use: a randomized clinical trial.
Badrfam R, Zandifar A, Hajialigol A, Rashidian M, Schmidt NB, Morabito D, Qorbani M, Shahrestanaki E, Mehrabani Natanzi M.
Psychopharmacology (Berl). 2024 Jul;241(7):1463-1476. doi: 10.1007/s00213-024-06577-x. Epub 2024 Mar 21.
Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel.
Camfield K, Reedy A, Wolf C, Al-Tayyib A, Rinehart D, Simpson SA; BEAT Meth MIPD Expert Panel.
Early Interv Psychiatry. 2024 Dec;18(12):1015-1021. doi: 10.1111/eip.13547. Epub 2024 May 21.
